Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate versus fluticasone propionate versus placebo in asthma
NL-OMON37429Phase 3Active, not recruiting
- Sponsor
- GSK
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone and fluticasone propionate in asthma (3 arms), sponsored by GSK. Primary endpoint: Change in trough FEV1 at week 24 from baseline. Started Dec 2011; status: active, not recruiting.
02
Drugs
fluticasonefluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON37429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37429.